Does Rallies show 13F holders for HCA?

Yes. Rallies tracks hedge fund and 13F ownership data for HCA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is HCA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HCA. It does not provide personalized investment advice.

HCA (HCA Healthcare, Inc.) Stock Analysis - Hedge Fund Holdings

HCA Healthcare, Inc. (HCA) is a publicly traded Healthcare sector company. As of May 21, 2026, HCA trades at $390.80 with a market cap of $93.79B and a P/E ratio of 20.74. HCA moved -1.85% today. Year to date, HCA is -16.99%; over the trailing twelve months it is +2.75%. Its 52-week range spans $289.98 to $556.52. Analyst consensus is buy with an average price target of $523.14. Rallies surfaces HCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns HCA stock?

Hedge funds tracked by Rallies that own HCA include Viking Global, Glenview Capital, Bridgewater Associates, Harris Associates, and Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for HCA Healthcare, Inc..

HCA Key Metrics

Key financial metrics for HCA
Metric	Value
Price	$390.80
Market Cap	$93.79B
P/E Ratio	20.74
EPS	$19.25
Dividend Yield	0.78%
52-Week High	$556.52
52-Week Low	$289.98
Volume	3.78K
Avg Volume	0
Revenue (TTM)	$64.97B
Net Income	$6.09B
Gross Margin	0.00%

Top Hedge Funds Holding HCA

Viking Global holds 1.08M shares of HCA, changed +7.60% as of Mar 31, 2026.
Glenview Capital holds 195.59K shares of HCA, changed +0.00% as of Jun 30, 2024.
Bridgewater Associates holds 173.80K shares of HCA, changed -47.22% as of Mar 31, 2026.
Harris Associates holds 158.14K shares of HCA, changed -12.65% as of Mar 31, 2026.
Panagora Asset holds 120.63K shares of HCA, changed -42.80% as of Mar 31, 2026.

Latest HCA News

HCA slides as weak Q1 seasonal volumes and new analyst cuts extend selloff — Apr 28, 2026
HCA jumps as 2026 outlook holds; senior-notes refinance plan draws fresh buyers — Apr 27, 2026
HCA drops as Q1 profitability misses expectations on weak seasonal volumes — Apr 26, 2026
HCA sinks after Q1 2026 adjusted EBITDA miss despite reaffirmed full-year guidance — Apr 25, 2026
HCA Healthcare Q1 EPS Hits $7.15 as Cash Flow Jumps 22% Despite Volume Headwinds — Apr 24, 2026

Recent HCA Insider Trades

McAlevey Michael R sold 1.69K (~$903.54K) on Feb 18, 2026.
Wyatt Christopher F. sold 4.00K (~$2.02M) on Feb 11, 2026.
Berres Jennifer sold 4.01K (~$2.02M) on Feb 11, 2026.

HCA Analyst Consensus

14 analysts cover HCA: 0 strong buy, 10 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $523.14.

Common questions about HCA

Who owns HCA stock?: Hedge funds tracked by Rallies that own HCA include Viking Global, Glenview Capital, Bridgewater Associates, Harris Associates, and Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for HCA Healthcare, Inc..
Does Rallies show 13F holders for HCA?: Yes. Rallies tracks hedge fund and 13F ownership data for HCA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HCA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HCA. It does not provide personalized investment advice.